Dr. Mark P. Weintraub, MD

Dr. Weintraub practices at Manatee Memorial Hospital in Bradenton, Florida, part of Universal Health Services.

Dr. Weintraub's NPI, 1053342386, was assigned on July 5, 2006. Dr. Weintraub graduated from Loyola University Chicago Stritch School of Medicine in 1985. Dr. Weintraub holds Florida license ME0068491.

Dr. Weintraub's primary practice is Manatee Memorial Hospital, at 206 2nd St E, Bradenton, FL 34208 in Manatee County. The practice phone is (941) 746-5111.

Dr. Weintraub's primary practice is Manatee Memorial Hospital in Bradenton, Florida, part of Universal Health Services. Dr. Weintraub is also affiliated with Lakewood Ranch Medical Center. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Weintraub to 2 more hospitals, 4 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weintraub practices, 9 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Weintraub's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Weintraub is board certified in urology by the American Board of Urology. Dmand AI has Dr. Weintraub's licenses on file in 3 states: Florida, California and Louisiana.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Weintraub treats.

CMS data shows 3,767 Medicare services from Dr. Weintraub across 21 procedure codes in 2024, for 654 Medicare patients. Medicare paid $118,980 for them.

CMS counts 654 Medicare patients who saw Dr. Weintraub in 2024. The largest group is 65 to 74, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weintraub's median patient age at 73, with 30% women.

In 2024, Dr. Weintraub wrote 2,776 Medicare Part D claims for 830 patients. 87% of them were for generic drugs. CMS names the drug for 2,614 of them, across 37 drugs with 11 or more claims each, at $1,960,996 in total drug cost. In 2023, CMS named 2,265 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Weintraub for performance year 2024, reported individually. Dr. Weintraub accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weintraub as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Weintraub.

CMS Open Payments shows 354 general payments to Dr. Weintraub from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Axonics, Inc. paid the most, $1,190.

Dmand AI lists 1 award for Dr. Weintraub, most recently CMS Stage 1 2012 in 2011.

Dr. Weintraub graduated from Loyola University Chicago Stritch School of Medicine in 1985.

Dr. Weintraub is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.